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 26 
Abstract  27 
Objectives To describe the features and diagnoses of a population of cats referred with 28 
pyrexia. Other aims were to report, and evaluate the utility of, clinical investigations 29 
performed, and describe any effect of treatment before referral on temperature at 30 
presentation and ability to make a diagnosis. 31 
 32 
Methods Clinical records of cats with pyrexia (≥39.2°C) documented at least twice were 33 
retrospectively reviewed. Cases were assigned into disease categories (infectious, 34 
inflammatory, immune-mediated, neoplastic, miscellaneous and no diagnosis [pyrexia of 35 
unknown origin, PUO]) based on diagnosis. The overall value of clinical investigations 36 
was assessed by classifying them as ‘enabling’, ‘assisting’ or ‘no assistance’ in achieving 37 
each diagnosis. The effect of treatment before referral was assessed for any association 38 
with temperature at presentation and ability to make a diagnosis (PUO versus other 39 
disease categories).  40 
 41 
Results 106 cases were identified. The most common cause of pyrexia was feline infectious 42 
peritonitis (22 cats, 20.8%) and the largest disease category was infectious (41/106, 38.7%). 43 
Inflammatory conditions were found in 19 (17.9%), neoplasia in 13 (12.3%), miscellaneous 44 
causes in 11 (10.4%) and immune-mediated disease in six (5.7%) cats. No diagnosis was 45 
reached in 16 (15.0%) cats, often despite extensive diagnostic investigations. Cytology and 46 
histopathology most often ‘enabled’ or ‘assisted’ in obtaining a diagnosis. Most cats (91 47 
cats, 85.8%) received treatment before referral, with antimicrobial treatment given to 48 
  
eighty-seven (82.1%) cats. Prior treatment before referral was not associated with 49 
temperature at presentation nor with success in establishing a diagnosis.  50 
 51 
Conclusions and relevance This is the first study investigating causes of pyrexia in cats. 52 
Infectious diseases were most common and immune-mediated diseases were 53 
comparatively rare. 54 
 55 
56 
  
Introduction 57 
 Pyrexia (fever) is an increased body temperature secondary to the release of 58 
pyrogens and a raised thermoregulatory set point in the anterior hypothalamus1. It is part 59 
of the non-specific adaptive response of the body to disease and is thought to confer a 60 
significant evolutionary advantage. However, there are disadvantages of pyrexia and 61 
these tend to outweigh benefits when pyrexia becomes more severe or prolonged1. Pyrexia 62 
that remains undiagnosed despite investigations is referred to as pyrexia of unknown 63 
origin (PUO). Over 200 diseases have been associated with PUO in humans2. Precise 64 
definitions of PUO vary; extrapolating from human medicine, PUO in dogs and cats has 65 
been defined as a temperature of ≥39.2°C (102.5°F) of at least three weeks duration in 66 
which no obvious cause is found following at least three visits to the veterinary surgeon 67 
and/or three days of hospitalisation (including basic evaluation of history, clinical signs, 68 
physical examination and diagnostic testing [complete blood count, serum biochemistry, 69 
urinalysis])1. Recommendations regarding the diagnostic approach to pyrexia have been 70 
described in cats1, 3, 4, but as no studies investigating causes of pyrexia have been published 71 
in cats, such recommendations are experience-based rather than evidence-based. It has 72 
been stated that infectious causes are the most common reason for feline pyrexia3, 5 but no 73 
published evidence exists. Immune-mediated disease is known to be the most common 74 
cause of pyrexia in dogs6-8. 75 
 The aims of the present study were to describe the population characteristics of cats 76 
with pyrexia referred to two veterinary referral centres and to identify the causes of 77 
pyrexia. Further objectives were to report the clinical investigations performed and 78 
evaluate their usefulness in obtaining a diagnosis, and to describe treatments given before 79 
  
referral and their possible effect on temperature at presentation and ability to reach a 80 
diagnosis.  81 
  
Methods 82 
 The clinical databases of feline patients referred to the Small Animal Hospital, 83 
University of Bristol and the Small Animal Hospital, University of Glasgow January 2011-84 
June 2015 were retrospectively searched to identify cats with pyrexia. Databases and 85 
clinician case logs were searched using the terms ‘pyrexia’, ‘pyrexic’, ‘PUO’ and ‘fever’. 86 
Case records were then retrospectively reviewed (SS) and appropriate details entered into 87 
a spreadsheet (Excel for Windows, Microsoft). Details regarding signalment, history, 88 
physical examination and minimum database were obtained in all cats. Peak temperature 89 
documented by the referring veterinarian within the past month and temperature at 90 
presentation to the referral centre were recorded. Further diagnostic investigations were 91 
performed depending on clinical presentation and the attending clinician’s discretion. To 92 
be included pyrexia (rectal temperature ≥39.2°C ([102.56°F]) had to have been documented 93 
at least twice (to reduce the risk of cats with stress hyperthermia being included), 94 
including at least once at the referring veterinary practice. Cases were excluded if records 95 
were inadequate. 96 
 The study was approved by the University of Bristol’s Animal Welfare and Ethical 97 
Review Body (veterinary investigation number [VIN] 16/019) and the University of 98 
Glasgow’s Research Ethics Committee (37a/16). 99 
 100 
Treatment before referral 101 
 Any drug administered by the referring practice after the initial documentation of 102 
pyrexia was recorded. As this included a large range of drugs, individual agents were 103 
grouped into therapeutic classes: non-steroidal anti-inflammatory drugs (NSAIDs), 104 
  
antimicrobials, corticosteroids, opioid analgesics, ‘supportive’ gastrointestinal medications 105 
(e.g, antiemetics, antacids), and miscellaneous drugs.  106 
 107 
Diagnostic investigations 108 
 Investigations performed by the referring veterinarian and at the referral centre 109 
were recorded. For the purpose of analysis, neutrophilia was graded as mild (12 to <20 x 110 
109/l), moderate (20 to <30 x 109/l) or severe (≥30 x 109/l); neutropenia was defined as <4 x 111 
109/L. Anaemia was classified as mild (PCV 20 to ≤24%), moderate (15 to <20%), or severe 112 
(<15%). Increases in alanine aminotransferase (ALT) were graded as mild (<2 times upper 113 
reference range), moderate (≥2 to 3 times), or severe (>3 times). Hypoalbuminaemia was 114 
classified as mild (20 to <24 g/l), moderate (16 to <20 g/l), or severe (<16 g/l).  115 
 Imaging techniques included ultrasonography, radiography, CT, MRI and 116 
endoscopy. Cytological examination was performed on fine needle aspirates from any 117 
abnormal masses or enlarged lymph nodes. Feline immunodeficiency virus (FIV) antibody 118 
and feline leukaemia virus (FeLV) antigen testing was initially performed using Petchek 119 
ELISA (IDEXX) or FeLV/FIV SNAP (IDEXX), with polymerase chain reaction (PCR) testing 120 
and/or virus isolation performed if results were positive.  121 
 Each diagnostic investigation was retrospectively categorised as: ‘enabled’ a 122 
diagnosis, ‘assisted’ a diagnosis, or of ‘no assistance’7. In cases where a negative result 123 
contributed to a diagnosis, the test was reported as ‘assisted’ a diagnosis. A complete 124 
blood count and serum biochemistry were performed in all cats, their usefulness in 125 
obtaining a diagnosis was not examined.  126 
  
  127 
Cause of pyrexia: disease groups 128 
 Cats were retrospectively assigned into one of the following disease groups based 129 
on final diagnosis: infectious, inflammatory, immune-mediated, neoplasia, miscellaneous 130 
and no diagnosis reached (PUO). Where more than one disease process from different 131 
categories was diagnosed, the disease attributed to be the cause of the pyrexia was 132 
classified. When this was unclear, cases were defined as miscellaneous.  133 
 134 
Outcome 135 
 Whether cats survived to discharge, were euthanased or died was recorded.  136 
 137 
Statistical analysis  138 
 Statistical analysis was performed using SPSS for Windows v23 (IBM Corp). 139 
Descriptive statistics were prepared for all evaluated variables. Kolmogorov-Smirnov tests 140 
were used to test for normality; continuous variables were reported as means and 141 
standard deviations (sd) if normally distributed, and as medians and ranges if not 142 
normally distributed.  143 
Overall treatment before referral (yes/no) was assessed for association with 144 
temperature at presentation using a T-test. Treatment was assessed for association with 145 
success in making a diagnosis (i.e, PUO [no diagnosis] vs all other disease categories 146 
[diagnosis reached]) using χ2 test. Significance was defined as P<0.05.  147 
  148 
  
Results 149 
One hundred and six cats met the inclusion criteria. 150 
 151 
Signalment  152 
Of the 106 cats, the most common breed was domestic (69 [65.1%]; 64 [60.4%] 153 
domestic shorthair, five [4.7%] domestic longhair); the remaining 37 (34.9%) cats were 154 
pedigrees. These comprised seven (6.6%) Ragdolls, six (5.7%) Bengals, six (5.7%) British 155 
shorthairs, five (4.7%) Birmans, four (3.8%) Maine coons, three (2.8%) Siamese, and one 156 
each (0.9%) of Balinese, Devon Rex, Korat, Oriental, Persian and Russian Blue.  Median 157 
age was 4.0 years (10 weeks–15 years).  158 
 159 
History and treatment before referral  160 
Diagnosis was known or suspected at the time of referral in 11 (10.3%) cats; these 161 
tended to be infectious (e.g, pyothorax, pyelonephritis, cellulitis), lymphoma (2 cats), or 162 
structural disease (e.g, ureteral obstruction, intestinal intussusception). Regarding cats 163 
with feline infectious peritonitis (FIP), two of 22 referring veterinarians mentioned FIP as a 164 
possible diagnosis at referral. Ninety-one cats (87.5%) received treatment before referral; 165 
treatment data were unavailable for two cases. Treatment had been given within 24-hours 166 
of referral in 77 (74.0%) cats. Antimicrobials were administered in 87 cats (83.7%) (Table 1); 167 
of these, 54 received one antimicrobial, 28 received antimicrobials from two different 168 
classes, and five from three different classes. Almost two-thirds of cats received NSAIDs 169 
(67/104, 64.4%) and approximately one-quarter received corticosteroids (25/104, 24.0%). 170 
Opioid analgesia was administered to 30 cats (28.8%), 26 cats (25.0%) received 171 
  
gastrointestinal support medication, and 20 cats (19.2%) received other miscellaneous 172 
drugs.  173 
Mean (+sd) peak temperature documented before referral was 40.1°C (+0.5°C). 174 
Pyrexia was reported to be present for a median of four days (1-168 days) before 175 
presentation. Eighty one cats (76.4%) were pyrexic at referral and mean temperature at 176 
presentation was 39.7°C (+0.6°C). Overall treatment before referral was not associated 177 
with temperature at presentation (P=0.543), nor with success in reaching a diagnosis 178 
(P=0.999). 179 
 180 
Diagnostic investigations 181 
The number of cats in which diagnostic investigations were performed and the 182 
usefulness of investigations in obtaining a diagnosis are shown in Table 2. Complete blood 183 
count and serum biochemistry were performed in all cats (results were unavailable in two 184 
cases). The most common abnormalities were neutrophil abnormalities and anaemia on 185 
complete blood count, and increased ALT and hypoalbuminaemia (Table 3) on serum 186 
biochemistry.  187 
 188 
Disease categories  189 
Final diagnoses and disease categories are listed in Table 4. Infectious disease 190 
represented the largest category (41/106, 38.7%). Within this category, FIP was diagnosed 191 
in 22 cases. Inflammatory (non-infectious) disease comprised the second most common 192 
disease category (19/106, 17.9%) and neoplastic disease third (13/106, 12.3%). Pyrexia was 193 
  
attributable to miscellaneous conditions in 11 cats (10.4%). Immune-mediated disease was 194 
the smallest disease category (6/106, 5.7%). No diagnosis (PUO) was established in 16 195 
cases (15.1%). The median ages of cats in each disease category are described in Table 5.  196 
 197 
Outcome  198 
Cats were hospitalised for a mean of 5.0 days (+3.2 days). Over two-thirds of cats 199 
(71/106, 67.0%) survived to discharge, 31 (29.2%) cats were euthanased and four (3.8%) 200 
died during hospitalisation.  201 
  202 
  
Discussion 203 
 This is this first published survey describing causes of pyrexia in referred cats. To 204 
the authors’ knowledge, there are no similar surveys of pyrexic cats in first opinion 205 
practice. Our study will therefore provide a useful comparison for future, ideally 206 
prospective, studies of pyrexic cats in both the first opinion, and referral, setting. Using 207 
the same grouping system previously described in a canine study7, we found infection to 208 
be the most common disease category. In contrast, immune-mediated disease was most 209 
commonly diagnosed in referral populations of pyrexic dogs6, 7. Infection is the most 210 
common cause for pyrexia in people2.  211 
  In terms of specific conditions, FIP was the most common diagnosis. Diagnosis was 212 
based on compatible clinicopathological findings and positive feline coronavirus 213 
immunostaining9,10. Intermittent fever is one of the earliest signs of FIP9 and in one study 214 
body temperature exceeded 39.5°C in 81% of cats with FIP, and over 40°C in almost half of 215 
cases10. FIP remains a difficult disease to definitively diagnose, perhaps in part due to the 216 
fluctuating nature of pyrexia meaning fever and clinical signs may falsely appear to 217 
respond to antimicrobials, delaying investigation and/or diagnosis. The high prevalence of 218 
FIP in this population where so many cats had received antimicrobials (±NSAIDs) 219 
highlights the condition as the most common cause of pyrexia refractory to empirical 220 
treatment. It is important to note that the prevalence of FIP may be abnormally high as the 221 
participating institutions actively participate in FIP research, possibly resulting in a biased 222 
population; it has been suggested that differences in disease category prevalence in canine 223 
studies has been in part due to particular interests of the authors6, 11. 224 
  
 Apart from FIP, few other specific infections were diagnosed in this study, despite 225 
FIV/FeLV testing, Toxoplasma gondii serology and other infectious disease PCR tests being 226 
commonly performed. This likely reflects the low prevalence of specific infectious diseases 227 
in the UK, especially at referral level, although it may also reflect inappropriate test 228 
selection by the clinician. The poor overall diagnostic value of routine serological and 229 
immunological tests is well known in human medicine and there is debate over the 230 
minimal serological tests indicated in PUO patients, due to the low prevalence of 231 
implicated diseases2.  232 
 Inflammatory (non-infectious) conditions comprised the second most common 233 
disease category in pyrexic cats, and interestingly, were almost as common as infectious 234 
causes when FIP cases were not considered. The widespread use of antimicrobials in this 235 
population may have resulted in infectious causes being incorrectly classified as 236 
inflammatory (e.g, sterile versus non-sterile cellulitis, bacterial versus non-bacterial 237 
cholangiohepatitis). This is a limitation inherent in the retrospective nature of the study 238 
and may have resulted in an underestimation of infectious disease prevalence.   239 
 Neoplasia as a cause for pyrexia was seen in 12.3% cats, comparable to figures 240 
described in pyrexic dogs (9.5%6 and 7.6%7). Unsurprisingly, as the most common feline 241 
neoplasm, lymphoma was the most prevalent neoplasm in this study. Primary pulmonary 242 
tumours were the second most frequent, found in three cats, and have previously been 243 
reported to cause pyrexia11, likely because of their propensity to become necrotic due to 244 
their often large and solid nature.  245 
  
Immune-mediated disease appears to be a less common cause for pyrexia in cats 246 
than in dogs6-8, with only immune-mediated haemolytic anaemia and immune-mediated 247 
polyarthritis diagnosed in our population. 248 
Despite often extensive investigations, a definitive diagnosis was not reached in 249 
15% of cases., comparable to canine studies6, 7. We hypothesise that cats with PUO had 250 
self-limiting infections or transient inflammatory foci. In the present study, although most 251 
cats were referred without a known diagnosis (and often referred to as having PUO by the 252 
referring veterinarian), a cause was found in 85% of cases. The term ‘PUO’ should 253 
therefore be reserved for cases where extensive diagnostics have failed to identify the 254 
cause. Not all cases of PUO in this study met the definition proposed by Ramsey & Tasker 255 
(2017)1, as only four out of 16 cats had a duration of illness of more than three weeks. This 256 
is perhaps not surprising as investigations and treatment are likely to be instigated much 257 
earlier than three weeks in order to reduce patient morbidity.  258 
Due to the retrospective nature of the study and assessment of survival data to 259 
discharge only, it was not possible to assess if PUO was associated with outcome. Overall 260 
survival to discharge (67.0%) was comparable however to a high (70%) survival rate 261 
reported in dogs with miscellaneous causes for pyrexia6. The majority of humans with 262 
PUO will eventually spontaneously recover12.  263 
No association between treatment and success in reaching a diagnosis was found. 264 
Treatment before referral was not associated with temperature at presentation, in contrast 265 
to dogs where prior treatment reduced the prevalence of pyrexia at the time of referral7. 266 
As pyrexia associated with FIP is expected to be refractory to treatment, the association of 267 
  
treatment before referral was also assessed in non-FIP cats only, and no significant 268 
association was found (unpublished data). Battersby et al. (2006) also reported that the 269 
treatment of pyrexia was associated with a longer time to diagnosis7. Because of this, and 270 
the proposed protective benefit of pyrexia, it has been recommended to reserve antipyretic 271 
drugs for cases where body temperature exceeds 41°C or clinical signs attributable to fever 272 
are severe1.  273 
Broad-spectrum antimicrobials are widely recommended for all cases of 274 
unexplained pyrexia in dogs and cats1, 3, 11, and in keeping with this recommendation, 275 
antimicrobials were the most commonly administered drugs given before referral in this 276 
study, in over 80% of cats. Furthermore, nearly one-third of all cats had received drugs 277 
from multiple antimicrobial classes by the time of referral. The prevalence of bacterial 278 
infections as a cause of pyrexia in first opinion veterinary practice may be sufficiently high 279 
to warrant such treatment, although no evidence exists to support this. Witholding 280 
antimicrobials in stable patients where fever is acute and mild is recommended in human 281 
medicine12. Of note, despite infections being regarded as (and shown to be in this study) 282 
the most common cause of feline pyrexia, almost one-quarter of cats had received 283 
corticosteroids before referral.  284 
A wide range of diagnostic investigations were employed to discern the cause of 285 
pyrexia. Complete blood count and serum biochemistry were performed in all cases but 286 
the most common abnormalities found (neutrophilia, increased ALT, anaemia and 287 
hypoalbuminaemia) were non-specific. Abdominal ultrasonography was the most 288 
commonly performed diagnostic procedure which ‘enabled’ or ‘assisted’ with a diagnosis 289 
  
in over half of the cats in which it was employed. Thoracic imaging (radiography and/or 290 
CT) was performed in over half of cats and appeared to be less useful than abdominal 291 
ultrasonography. Echocardiography was performed in approximately one-third of cats 292 
but only assisted with diagnosis in one cat (diagnosed with myocarditis); indeed it was 293 
seemingly performed in the majority of cases to assess for concurrent cardiac disease due 294 
to the detection of a heart murmur or gallop sounds, as well as to assess for endocarditis. 295 
Our data suggests that diagnostic imaging selection in pyrexic cats should depend on 296 
localising signs (eg, MRI of the brain ‘assisted’ or ‘enabled’ a diagnosis in all cases 297 
presented with neurological signs) rather than seeking abnormalities without appropriate 298 
localisation. 299 
Fluid (pleural or peritoneal) analysis was a highly useful diagnostic test when 300 
performed, likely due to its importance in aiding FIP diagnosis. Cytology and 301 
histopathology were widely employed and were very useful diagnostic procedures, in 302 
agreement with canine studies6-8. Bacterial culture (eg, of fluid, tissue) ‘enabled’ or 303 
‘assisted’ with a diagnosis in approximately one-third of cases in which it was performed, 304 
although false negative results may have occurred due to previous antimicrobial therapy 305 
or difficulty in culturing certain organisms (e.g. Mycoplasma spp.). Interestingly, blood 306 
culture was performed in only one cat and even though this test is often recommended 307 
when investigating feline pyrexia3, 11 it does not appear to be a principal test required for 308 
diagnosis. Feline pancreatic lipase immunoreactivity was performed in over one-quarter 309 
of cats, likely due to its widespread availability as a bench-side test and due to the non-310 
specific clinical signs of feline pancreatitis (anorexia, lethargy). Its usefulness in obtaining 311 
  
a diagnosis was fairly low, however, perhaps due to pancreatitis being an uncommon 312 
cause of pyrexia, and/or due to the test’s limitations in diagnosing chronic or mild forms 313 
of the condition13.  314 
The study’s population comprised referral cases and therefore likely contained 315 
cases where fever did not spontaneously resolve or respond to empirical treatment, where 316 
localising signs were absent, where simple diagnostic tests failed to identify a cause, or 317 
alternatively where a diagnosis was known but intensive management was required. 318 
Ultimately many patients were found to have relatively common conditions (e.g, 319 
pancreatitis, lymphoma, cellulitis) and merely had an unusual or early manifestation of 320 
these diseases that hindered diagnosis prior to referral. 321 
Limitations of this study are largely due to its retrospective nature. Future studies 322 
should focus on a prospective cohort of cats being referred with pyrexia. A larger number 323 
of cases would also enable statistical tests to be performed to further investigate features 324 
of the different disease categories and the diagnostic investigations performed. 325 
Appropriate cases may have been missed due to the search methods employed (e.g, 326 
misspelling of pyrexia) and incomplete records meant that some cases had to be excluded. 327 
Interpretation of records was required in some instances to determine the final diagnosis 328 
and disease category classification. Follow-up data were limited in that only survival to 329 
discharge was known in the majority of cases. Finally, despite the endeavour to exclude 330 
hyperthermic cats, it is still possible that some cases (particularly cats with respiratory 331 
impairment) may have been hyperthermic. Furthermore, a few conditions diagnosed in 332 
this study have not been previously associated with pyrexia (e.g, renal pseudocysts, 333 
  
uroliths, gastrointestinal foriegn bodies); while it is feasible pyrexia may occur in these 334 
conditions due to inflammation and/or associated infection, hyperthermia cannot be fully 335 
excluded. Rectal temperature in healthy cats can reach 39.3°C in the veterinary 336 
consultation room due to stress14. The inclusion criteria of two or more documented 337 
episodes of increased rectal temperature was used in an attempt to exclude cases with 338 
stress hyperthermia. 339 
  340 
  
Conclusions 341 
This is the first descriptive study investigating cases of feline pyrexia. A diligent 342 
search for an infectious cause, particularly FIP, remains a priority in the investigation of 343 
cats with pyrexia. In contrast to dogs, immune-mediated disease is a rare cause for feline 344 
pyrexia. Abdominal ultrasonography and cytology are likely to be useful and readily 345 
available diagnostic procedures. The administration of more than one antimicrobial class 346 
was common in this population.  347 
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Table 1. Antimicrobials administered before referral in a population of 106 cats with 362 
pyrexia 363 
 364 
One antimicrobial administered (n=54) 
AC 35 
Cefovecin 9 
Fluoroquinolone 4 
Clindamycin 4 
Two antimicrobials administered (n=28) 
AC / fluoroquinolone 12 
AC / metronidazole 6 
AC / cefovecin 3 
AC / doxycycline 3 
AC / clindamycin 1 
Fluoroquinolone / cefovecin 1 
Fluoroquinolone / TMPS 1 
Fluoroquinolone / clindamycin 1 
Three or more antimicrobials administered (n=5) 
AC / cefovecin / metronidazole 2 
AC / cefovecin / clindamycin 2 
AC / cefovecin / doxycycline / 
fluoroquinolone 
1 
 365 
AC = amoxicillin-clavulanic acid; TMPS = trimethoprim sulfonamide 366 
Numbers (n) indicate number of cats  367 
  
 368 
Table 2. Utility of diagnostic tests/investigations performed in 106 cats with pyrexia 369 
Test 
Number of cats in which 
test was performed 
(percentage) 
Number of cats 
in which test 
‘Enabled a 
diagnosis’ 
(percentage) 
Number of cats 
in which test 
‘Assisted a 
diagnosis’ 
(percentage) 
Urinalysis 46 (43.4%) 0 2 (4.3%) 
Urine culture 31 (29.2%) 3 (9.7%) 0 
FeLV/FIV testing 74 (69.8%) 
FIV positive = 3 
(4.0%) 
0 
Feline PLI 28 (26.4%) 3 (10.7%)  0 
Abdominal 
ultrasonography 
74 (69.8%) 11 (14.9%) 28 (37.8%) 
Abdominal CT 9 (8.5%) 0 1 (11.1%) 
Thoracic radiography 39 (36.8%) 0 7 (18.9%) 
Thoracic CT 26 (24.5%) 1 (3.8%) 6 (23.1%) 
Echocardiography 33 (31.1%) 0 
0  
(concurrent 
cardiomyopathy  
= 3) 
MRI 7 (6.6%) 1 (14.3%) 6 (85.7%) 
Other imaging (e.g, 
CT/radiography of 
head, joints) 
7 (6.6%) 1 (14.3%) 6 (85.7%) 
Endoscopy 
Bronchoscopy 6 (5.7%)  
GI endoscopy 3 (2.8%) 
Rhinoscopy 1 (0.9%) 
1 (16.7%) 3 (30%) 
Bacterial culture  
(non-urine e.g, fluid, 
tissue) 
31 (29.2%)  5 (16.1%) 5 (16.1%) 
Cytology 43 (40.6%)  16 (25.4%) 12 (27.9%) 
Body cavity fluid 
analysis 
30 (28.3%) 5 (16.6%) 19 (63.3%) 
Histopathology 26 (24.5%) 13 (50.0%) 7 (26.9%) 
Faecal tests  
(culture, parasitology)  
8 (7.5%)  0 3 (37.5%) 
  
Test 
Number of cats in which 
test was performed 
(percentage) 
Number of cats 
in which test 
‘Enabled a 
diagnosis’ 
(percentage) 
Number of cats 
in which test 
‘Assisted a 
diagnosis’ 
(percentage) 
PCR  
(blood, tissue, saliva) 
FCoV 15 (14.2%) 
Haemoplasma 8 (7.5%) 
Mycoplasma felis 5 
(4.7%) 
FCV 5 (4.7%) 
FHV 4 (3.8%) 
Toxoplasma gondii 4 
(3.8%) 
Bordetella bronchiseptica 
4 (3.8%) 
Tritrochomonas foetus 1 
(0.9%) 
Mycobacteria species 1 
(0.9%) 
6 (12.8%) 13 (27.7%) 
Serology  
T. gondii 22 (20.8%) 
FCoV 19 (18.8%) 
2 (4.9%) 17 (41.4%) 
Other tests performed 
but not further 
described 
Alpha-1 glycoprotein, serum troponins, serum electrophoresis, bile 
acids, thyroxine, coagulation testing, serum cobalamin/folate, 
serum ammonia, electrocardiogram, gamma interferon testing, 
Coombs’ testing, Ziehl Neelsen staining 
 370 
FeLV = Feline leukemia virus, FIV = Feline immunodeficiency virus, PLI = pancreatic 371 
lipase immunoreactivity, GI = gastrointestinal, FCoV = Feline coronavirus, FCV = Feline 372 
calicivirus, FHV = Feline herpesvirus PCR = polymerase chain reaction 373 
  374 
  
Table 3. Most common complete blood count and serum biochemistry abnormalities 375 
detected in 104 cats with pyrexia 376 
 377 
Laboratory parameter 
Number of 
cases 
Neutrophil abnormalities  50 
    Mild neutrophilia 13 
    Moderate neutrophilia 14 
    Severe neutrophilia 9 
    Band neutrophilia (normal overall neutrophil count) 7 
    Neutropenia 7 
Anaemia 39 
    Mild 18 
    Moderate 17 
    Severe 4 
Increased alanine transaminase  (ALT) 48 
    Mild 37 
    Moderate 9 
    Severe 2 
Hypoalbuminaemia 32 
   Mild 14 
   Moderate 14 
   Severe 4 
 378 
 379 
Neutrophilia: mild (12 to <20 x 109/l), moderate (20 to <30 x 109/l), severe (≥30 x 109/l). 380 
Neutropenia: <4 x 109/L. Anaemia: mild (PCV 20 to ≤24%), moderate (15 to <20%), 381 
severe (<15%). ALT: mild (<2 times upper reference range), moderate (≥2 to 3 times), 382 
severe (>3 times). Hypoalbuminaemia: mild (20 to <24 g/l), moderate (16 to <20 g/l), 383 
severe (<6 g/l). 384 
  385 
  
 386 
Table 4. Final diagnosis and disease category classification for 106 cats with 387 
pyrexia 388 
Disease group Diagnosis Number of cats 
Infectious FIP 
Cellulitis/otitis (media) 
Pyothorax  
Pyelonephritis/UTI 
Lower airway inflammation with M.felis 
Neutrophilic cholangiohepatitis 
Campylobacter enteritis 
Bronchopneumonia  
Brain empyema 
Hepatic abscess  
TOTAL 
22 
4 
3 
3 
2 
2 
2 
1 
1 
1 
41 (38.7%) 
Inflammatory  Pancreatitis 
Sterile peritonitis 
Sterile lymphadenitis/panniculitis/cellulitis 
Inflammatory lower airway disease 
Lymphocytic cholangiohepatitis  
Inflammatory CNS disease 
Myocarditis  
TOTAL 
5 
3 
3 
3 
2 
2 
1 
19 (17.9%) 
Neoplasia Lymphoma  
Pulmonary carcinoma 
Leukaemia (not characterised) 
Pulmonary metastases, primary neoplasm not 
identified  
Gastrointestinal adenocarcinoma 
TOTAL 
6 
3 
2 
1 
 
1 
13 (12.3%) 
Immune-
mediated  
Immune-mediated haemolytic anaemia 
Immune-mediated polyarthritis 
TOTAL 
3 
3 
6 (5.7%) 
Miscellaneous Intestinal obstruction (foreign body)  
Bone marrow disorder (not characterised) 
Ureterolithiasis/urolithiasis  
Intussusception  
Peri-renal pseudocysts 
Trauma 
Hippocampal necrosis 
TOTAL 
3 
2 
2 
1 
1 
1 
1 
11 (10.4%) 
No diagnosis 
(PUO) 
TOTAL 16 (15.0%) 
 389 
 390 
  
FIP = Feline infectious peritonitis, UTI = urinary tract infection, CNS = central nervous 391 
system, PUO = pyrexia of unknown origin 392 
  
Table 5. Median age of 106 cats with pyrexia, as classified by disease category  
 
 
PUO = pyrexia of unknown origin  
Disease groups All cats Infectious  Inflammatory  Neoplasia Miscellaneous 
Immune-
mediated  
No diagnosis 
(PUO) 
Median (range) age 
(years) 
4.0 (0.2 – 15) 2.5 (0.1-15.0) 5.0 (0.6-12.0) 
8.0  
(1.0-14.0) 
3.0 (0.6-8.0) 8.5 (1.0-13.0) 3.0 (0.1-14.0) 
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